Currently, Rafael G. Amado holds the position of Chief Medical Officer, EVP-Research & Development at Allogene Therapeutics, Inc.
Dr. Amado previously was President-Research & Development at Adaptimmune Therapeutics Plc, Senior Vice President of GlaxoSmithKline Plc and Executive Director-Therapeutic Oncology at Amgen Ltd.
Dr. Amado received a doctorate from the University of Seville.
|